









Markets
/
Stocks
/
nasdaq-ipsc
/

Century Therapeutics Inc

IPSC

0.477USD

-0.030-5.88%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

41.19MMarket Cap

LossP/E TTM



Century Therapeutics Inc

0.477

-0.030-5.88%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

-100.00%0.00

12667.72%109.16M

1457.09%4.17M

434.46%791.00K

678.79%771.00K

-50.29%855.00K

-48.56%268.00K

-93.35%148.00K

-92.91%99.00K

62.57%1.72M

--521.00K

--2.22M

--1.40M

--1.06M

----

Revenue

-100.00%0.00

12667.72%109.16M

1457.09%4.17M

434.46%791.00K

678.79%771.00K

-50.29%855.00K

-48.56%268.00K

-93.35%148.00K

-92.91%99.00K

62.57%1.72M

--521.00K

--2.22M

--1.40M

--1.06M

----

Operating expenses

-2.43%34.66M

8.78%34.99M

20.22%37.13M

11.98%35.58M

14.76%35.53M

-4.84%32.16M

-8.70%30.89M

-6.44%31.77M

-5.47%30.96M

18.62%33.80M

20.93%33.83M

31.50%33.96M

42.25%32.75M

57.76%28.49M

--27.97M

96.69%25.83M

113.28%23.02M

80.75%18.06M

--13.13M

--10.79M

--9.99M

R&D expenses

-1.33%26.86M

13.49%26.58M

31.75%29.38M

19.48%27.23M

19.77%27.22M

-5.94%23.42M

-12.86%22.30M

-12.01%22.79M

-7.21%22.73M

17.47%24.90M

17.38%25.59M

32.50%25.90M

29.37%24.49M

37.87%21.20M

--21.80M

80.77%19.55M

123.16%18.93M

93.55%15.37M

--10.81M

--8.48M

--7.94M

Depreciation, depletion, and amortization

-7.54%3.20M

-0.15%3.22M

-6.59%3.32M

-1.55%3.30M

5.81%3.46M

8.84%3.23M

22.19%3.55M

17.46%3.35M

87.61%3.27M

139.81%2.96M

157.71%2.91M

154.42%2.85M

72.33%1.74M

55.86%1.24M

--1.13M

164.39%1.12M

258.87%1.01M

296.50%793.00K

--424.00K

--282.00K

--200.00K

Operating profit

0.26%-34.66M

336.92%74.18M

-7.64%-32.96M

-10.00%-34.79M

-12.63%-34.76M

2.41%-31.31M

8.07%-30.62M

0.35%-31.63M

1.58%-30.86M

-16.93%-32.08M

-19.06%-33.31M

-22.89%-31.74M

-36.18%-31.35M

-51.90%-27.44M

---27.97M

-96.69%-25.83M

-113.28%-23.02M

-80.75%-18.06M

---13.13M

---10.79M

---9.99M

Net non-operating interest income (expenses)

Non-operating interest income

-43.89%2.01M

-25.18%2.42M

-17.92%2.88M

-5.19%3.31M

17.14%3.58M

23.41%3.24M

--3.51M

--3.49M

--3.06M

--2.62M

----

Non-operating interest expense

----

--0.00

-100.00%0.00

-58.79%136.00K

28.66%404.00K

28.66%413.00K

15.84%373.00K

3.77%330.00K

0.00%314.00K

--321.00K

445.76%322.00K

--318.00K

--314.00K

--59.00K

--0.00

Gains from sale of securities

----

1346.85%2.07M

890.71%1.39M

977.27%711.00K

803.57%253.00K

--143.00K

16.67%140.00K

-69.30%66.00K

-91.25%28.00K

--120.00K

--215.00K

--320.00K

Special income (expenses)

----

67.08%-4.33M

100.00%0.00

----

---13.14M

---4.00M

---4.22M

100.00%0.00

--0.00

---10.00M

--0.00

100.00%0.00

----

--0.00

---4.72M

----

Other non-operating income (expenses)

1041.67%113.00K

-445.45%-38.00K

806.67%106.00K

1983.33%250.00K

93.55%-12.00K

105.67%11.00K

---15.00K

--12.00K

---186.00K

---194.00K

----

Income before tax

-4.35%-32.54M

372.83%76.56M

14.83%-34.30M

2.78%-31.23M

3.57%-31.18M

6.64%-28.06M

-27.23%-40.27M

-4.57%-32.13M

-4.43%-32.34M

19.84%-30.06M

-12.43%-31.65M

-18.13%-30.72M

-33.07%-30.97M

-104.37%-37.50M

---28.15M

-99.00%-26.01M

-52.10%-23.27M

-89.68%-18.35M

---13.07M

---15.30M

---9.67M

Income tax

----

-100.00%0.00

304.37%1.78M

-101.35%-8.00K

-97.68%22.00K

-99.92%1.00K

-2815.63%-869.00K

2268.00%592.00K

5177.78%950.00K

7450.00%1.21M

-25.58%32.00K

--25.00K

--18.00K

--16.00K

--43.00K

----

Income after tax

-4.27%-32.54M

372.82%76.56M

8.44%-36.07M

4.57%-31.23M

6.26%-31.21M

10.24%-28.06M

-24.35%-39.40M

-6.41%-32.72M

-7.43%-33.29M

16.66%-31.26M

-12.37%-31.68M

-18.22%-30.75M

-33.15%-30.99M

-104.45%-37.51M

---28.19M

-99.00%-26.01M

-52.10%-23.27M

-89.68%-18.35M

---13.07M

---15.30M

---9.67M

Net income from continuous operations

-4.27%-32.54M

372.82%76.56M

8.44%-36.07M

4.57%-31.23M

6.26%-31.21M

10.24%-28.06M

-24.35%-39.40M

-6.41%-32.72M

-7.43%-33.29M

16.66%-31.26M

-12.37%-31.68M

-18.22%-30.75M

-33.15%-30.99M

-104.45%-37.51M

---28.19M

-99.00%-26.01M

-52.10%-23.27M

-89.68%-18.35M

---13.07M

---15.30M

---9.67M

Net income attributable to controlling interests

-4.27%-32.54M

372.82%76.56M

8.44%-36.07M

4.57%-31.23M

6.26%-31.21M

10.24%-28.06M

-24.35%-39.40M

-6.41%-32.72M

-7.43%-33.29M

16.66%-31.26M

-12.37%-31.68M

-18.22%-30.75M

-33.15%-30.99M

-104.45%-37.51M

---28.19M

-99.00%-26.01M

-52.10%-23.27M

-89.68%-18.35M

---13.07M

---15.30M

---9.67M

Net income attributable to common shareholders

-4.27%-32.54M

372.82%76.56M

8.44%-36.07M

4.57%-31.23M

6.26%-31.21M

10.24%-28.06M

-24.35%-39.40M

-6.41%-32.72M

-7.43%-33.29M

16.66%-31.26M

-12.37%-31.68M

-18.22%-30.75M

-33.15%-30.99M

-104.45%-37.51M

---28.19M

-99.00%-26.01M

-52.10%-23.27M

-89.68%-18.35M

---13.07M

---15.30M

---9.67M

Basic earnings per share

0.74%-0.38

297.58%0.89

35.69%-0.42

33.02%-0.37

32.34%-0.38

15.55%-0.45

-20.85%-0.66

-3.77%-0.55

-4.59%-0.56

18.88%-0.53

-6.11%-0.54

-11.09%-0.53

72.20%-0.54

72.49%-0.66

---0.51

72.67%-0.48

5.52%-1.93

-84.86%-2.39

---1.75

---2.05

---1.29

Diluted earnings per share

0.74%-0.38

297.40%0.89

35.69%-0.42

33.02%-0.37

32.34%-0.38

15.55%-0.45

-20.85%-0.66

-3.77%-0.55

-4.59%-0.56

18.88%-0.53

-6.11%-0.54

-11.09%-0.53

72.20%-0.54

72.49%-0.66

---0.51

72.67%-0.48

5.52%-1.93

-84.86%-2.39

---1.75

---2.05

---1.29

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

